Graft-versus-host disease
Haemopoietic-cell transplantation (HCT) is an intensive therapy used to treat high-risk
haematological malignant disorders and other life-threatening haematological and genetic …
haematological malignant disorders and other life-threatening haematological and genetic …
[HTML][HTML] Phagocytosis of apoptotic cells in homeostasis
Human bodies collectively turn over about 200 billion to 300 billion cells every day. Such
turnover is an integral part of embryonic and postnatal development, as well as routine …
turnover is an integral part of embryonic and postnatal development, as well as routine …
Advances in graft-versus-host disease biology and therapy
Allogeneic haematopoietic stem cell transplantation is used to treat a variety of disorders,
but its efficacy is limited by the occurrence of graft-versus-host disease (GVHD). The past …
but its efficacy is limited by the occurrence of graft-versus-host disease (GVHD). The past …
Pathophysiology of GvHD and other HSCT-related major complications
S Ghimire, D Weber, E Mavin, XN Wang… - Frontiers in …, 2017 - frontiersin.org
For over 60 years, hematopoietic stem cell transplantation has been the major curative
therapy for several hematological and genetic disorders, but its efficacy is limited by the …
therapy for several hematological and genetic disorders, but its efficacy is limited by the …
Guidelines on the use of extracorporeal photopheresis
R Knobler, G Berlin, P Calzavara‐Pinton… - Journal of the …, 2014 - Wiley Online Library
Background After the first investigational study on the use of extracorporeal photopheresis
for the treatment of cutaneous T‐cell lymphoma was published in 1983 with its subsequent …
for the treatment of cutaneous T‐cell lymphoma was published in 1983 with its subsequent …
[HTML][HTML] Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease
D Wolff, M Schleuning, S von Harsdorf, U Bacher… - Biology of Blood and …, 2011 - Elsevier
Steroid refractory chronic graft-versus-host disease (cGVHD) is associated with a significant
morbidity and mortality. Although first-line treatment of cGVHD is based on controlled trials …
morbidity and mortality. Although first-line treatment of cGVHD is based on controlled trials …
European dermatology forum–updated guidelines on the use of extracorporeal photopheresis 2020–part 1
R Knobler, P Arenberger, A Arun… - Journal of the …, 2020 - Wiley Online Library
Background Following the first investigational study on the use of extracorporeal
photopheresis for the treatment of cutaneous T‐cell lymphoma published in 1983, this …
photopheresis for the treatment of cutaneous T‐cell lymphoma published in 1983, this …
Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape
HT Greinix, F Ayuk, R Zeiser - Leukemia, 2022 - nature.com
Patients with steroid-refractory graft-versus-host disease (GvHD) are known to have a poor
prognosis and for decades no approved drug has been available to treat this serious …
prognosis and for decades no approved drug has been available to treat this serious …
Extracorporeal photopheresis—an overview
A Cho, C Jantschitsch, R Knobler - Frontiers in medicine, 2018 - frontiersin.org
Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after
receiving FDA approval for the palliative treatment of the Sézary Syndrome variant of …
receiving FDA approval for the palliative treatment of the Sézary Syndrome variant of …
Pathogenesis and management of graft-versus-host disease
SW Choi, JE Levine… - … and Allergy Clinics, 2010 - immunology.theclinics.com
Allogeneic hematopoietic cell transplantation (HCT) is an important therapeutic option for
various malignant and nonmalignant conditions. 1 The indication for its use has expanded …
various malignant and nonmalignant conditions. 1 The indication for its use has expanded …